300 related articles for article (PubMed ID: 23746430)
1. Emerging pharmacotherapies for alcohol dependence: a systematic review focusing on reduction in consumption.
Aubin HJ; Daeppen JB
Drug Alcohol Depend; 2013 Nov; 133(1):15-29. PubMed ID: 23746430
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials.
Falk DE; O'Malley SS; Witkiewitz K; Anton RF; Litten RZ; Slater M; Kranzler HR; Mann KF; Hasin DS; Johnson B; Meulien D; Ryan M; Fertig J;
JAMA Psychiatry; 2019 Apr; 76(4):374-381. PubMed ID: 30865232
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate.
Palpacuer C; Duprez R; Huneau A; Locher C; Boussageon R; Laviolle B; Naudet F
Addiction; 2018 Feb; 113(2):220-237. PubMed ID: 28940866
[TBL] [Abstract][Full Text] [Related]
4. Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials.
Palpacuer C; Laviolle B; Boussageon R; Reymann JM; Bellissant E; Naudet F
PLoS Med; 2015 Dec; 12(12):e1001924. PubMed ID: 26694529
[TBL] [Abstract][Full Text] [Related]
5. Evaluation in alcohol use disorders - insights from the nalmefene experience.
Naudet F; Palpacuer C; Boussageon R; Laviolle B
BMC Med; 2016 Aug; 14(1):119. PubMed ID: 27534932
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapy for Alcohol Dependence: The 2015 Recommendations of the French Alcohol Society, Issued in Partnership with the European Federation of Addiction Societies.
Rolland B; Paille F; Gillet C; Rigaud A; Moirand R; Dano C; Dematteis M; Mann K; Aubin HJ
CNS Neurosci Ther; 2016 Jan; 22(1):25-37. PubMed ID: 26768685
[TBL] [Abstract][Full Text] [Related]
7. Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacy.
Mann K; Torup L; Sørensen P; Gual A; Swift R; Walker B; van den Brink W
Eur Neuropsychopharmacol; 2016 Dec; 26(12):1941-1949. PubMed ID: 27842940
[TBL] [Abstract][Full Text] [Related]
8. Treatment of alcohol dependence: recent progress and reduction of consumption.
Testino G; Leone S; Borro P
Minerva Med; 2014 Dec; 105(6):447-66. PubMed ID: 25392958
[TBL] [Abstract][Full Text] [Related]
9. Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-Analysis.
Soyka M; Friede M; Schnitker J
Pharmacopsychiatry; 2016 Mar; 49(2):66-75. PubMed ID: 26845589
[TBL] [Abstract][Full Text] [Related]
10. A Trial-Based Predictive Microsimulation Assessing the Public Health Benefits of Nalmefene and Psychosocial Support for the Reduction of Alcohol Consumption in Alcohol Dependence.
Laramée P; Millier A; Rahhali N; Cristeau O; Aballéa S; François C; Chalem Y; Toumi M; Rehm J
Appl Health Econ Health Policy; 2016 Aug; 14(4):493-505. PubMed ID: 27283839
[TBL] [Abstract][Full Text] [Related]
11. Comparing topiramate with naltrexone in the treatment of alcohol dependence.
Baltieri DA; Daró FR; Ribeiro PL; de Andrade AG
Addiction; 2008 Dec; 103(12):2035-44. PubMed ID: 18855810
[TBL] [Abstract][Full Text] [Related]
12. Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone.
Martinotti G; Di Nicola M; Di Giannantonio M; Janiri L
J Psychopharmacol; 2009 Mar; 23(2):123-9. PubMed ID: 18515460
[TBL] [Abstract][Full Text] [Related]
13. The state of pharmacotherapy for the treatment of alcohol dependence.
Garbutt JC
J Subst Abuse Treat; 2009 Jan; 36(1):S15-23; quiz S24-5. PubMed ID: 19062347
[TBL] [Abstract][Full Text] [Related]
14. Recent Developments in Pharmacotherapy of Alcoholism.
Soyka M; Lieb M
Pharmacopsychiatry; 2015 Jul; 48(4-5):123-35. PubMed ID: 25761458
[TBL] [Abstract][Full Text] [Related]
15. Review of topiramate: an antiepileptic for the treatment of alcohol dependence.
Kenna GA; Lomastro TL; Schiesl A; Leggio L; Swift RM
Curr Drug Abuse Rev; 2009 May; 2(2):135-42. PubMed ID: 19630744
[TBL] [Abstract][Full Text] [Related]
16. Opioid Receptor Antagonists in the Treatment of Alcoholism.
Serecigni JG
Adicciones; 2015 Sep; 27(3):214-30. PubMed ID: 26437315
[TBL] [Abstract][Full Text] [Related]
17. The Cost Effectiveness of Nalmefene for Reduction of Alcohol Consumption in Alcohol-Dependent Patients with High or Very High Drinking-Risk Levels from a UK Societal Perspective.
Brodtkorb TH; Bell M; Irving AH; Laramée P
CNS Drugs; 2016 Feb; 30(2):163-77. PubMed ID: 26879458
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.
Bouza C; Angeles M; Muñoz A; Amate JM
Addiction; 2004 Jul; 99(7):811-28. PubMed ID: 15200577
[TBL] [Abstract][Full Text] [Related]
19. Vibration of effects from diverse inclusion/exclusion criteria and analytical choices: 9216 different ways to perform an indirect comparison meta-analysis.
Palpacuer C; Hammas K; Duprez R; Laviolle B; Ioannidis JPA; Naudet F
BMC Med; 2019 Sep; 17(1):174. PubMed ID: 31526369
[TBL] [Abstract][Full Text] [Related]
20. Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence.
Keating GM
Clin Drug Investig; 2014 Jan; 34(1):63-80. PubMed ID: 24307430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
